Trilogy Tissue Marker
Marker, Radiographic, Implantable. 510(k) K240429, from Inrad, Inc. (Kentwood, MI). Product code NEU, class 2.
As of Nov 19, 2026, K240429 is an FDA 510(k) held by Inrad, Inc., substantially equivalent on Nov 7, 2024 after 268 days, with no recalls tied to it in FDA's recall database.
- Review time: 268 days
- Recalls: 0
The Trilogy Tissue Marker is intended for use to attach to breast tissue at the surgical site during an open surgical breast biopsy or percutaneous breast biopsy to radiographically mark the location of the biopsy procedure, and be permanently visible under MRI, x-ray and ultrasound.
- EasyMark Tissue MarkerK183503 · Inrad, Inc. · Oct 17, 2019
- HydroMARK™ Plus Breast Biopsy Site Marker (Dragonfly Shape); HydroMARK™ Plus Breast Biopsy Site Marker (Hummingbird…K253761 · Devicor Medical Products, Inc. · Jan 23, 2026
- MOLLI 2 SystemK253888 · Stryker Endoscopy · Dec 31, 2025
- SCOUT MD Surgical Guidance SystemK252892 · Merit Medical Systems, Inc. · Dec 19, 2025
- VizMark Preloaded Tissue Marker Device (VM-0001)K251989 · Breast-Med, Inc. · Dec 12, 2025
- MammoSTAR Biopsy Site IdentifierK251748 · Carbon Medical Technologies, Inc. · Jul 23, 2025
- UltraCor™ Twirl™ Breast Tissue MarkerK243642 · Bard Peripheral Vascular, Inc. · Mar 24, 2025
- SmartClip Secure Soft Tissue MarkerK233639 · Elucent Medical, Inc. · Dec 20, 2024
- MOLLI 2 SystemK234149 · Molli Surgical, Inc. · Sep 26, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Feb 13, 2024
- Review panel
- General, Plastic Surgery
- Regulation
- 21 CFR 878.4300
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files